22 GHP Q3 2024 Determined to help people make the right decisions about which supplements are the best for their specific health needs, it is the mission of PrecisionBiotics® to both unlock and share the natural power of the human microbiome, empowering individuals to take back control of their health for good. Aside from a speciality in digestive health reflected in the title that has been bestowed upon it, other areas of focus for this company include mental health and wellbeing and immune health, with both female- and child-specific supplements also available. A company that is both at the forefront of modern microbiome science and comprised of global probiotic pioneers, PrecisionBiotics® boasts a track record of relieving such issues as IBS and stress effectively, which can have a significant impact on an individual’s day-to-day quality of life. By basing its products on unique customer insights and the needs of consumers, this brand has become one that is trusted by both the people and the healthcare community alike. From emphasising the importance of scientific research and standardised clinical trials to investing in ongoing R&D to further enhance the benefits of its solutions, PrecisionBiotics® continues to carve out a name for itself as a frontrunner in the probiotics industry, leveraging its scientific integrity and customer-first approach to craft quality probiotic products that are all validated by science. The company’s standout nature is perhaps best seen in its Alflorex® range, which represents a breakthrough in the largely untapped field of digestive health. Encompassing the revolutionary 35624™bacteria culture – which hails from the Bifidobacterial Longum family and has been proven to reduce bloating, abdominal pain, and irregular bowel habits as a result of IBS – Alflorex® works by specifically targeting the microorganisms in the gut, ultimately resulting in a healthy and more balanced digestive system. The 35624™ bacteria used in this solution was taken from the human gut in the first place and Jul24164 D For more than 20 years, PrecisionBiotics® has been researching probiotic cultures and enzymes, measuring the impact they have on our bodies and identifying which unique strands of ‘good’ bacteria help target certain specific health conditions. The result has been the development of a series of clinically proven probiotics that offer solutions to some of the most common health problems we as a society face today. Named as the Best Gut Health Supplement Brand 2024, every product in this company’s portfolio is tested, backed by data, and has been validated to the highest scientific standards. has been recognised internationally for its effectiveness in managing IBS. According to a realworld study carried out using the unique 35624™ culture demonstrated a reduction of such IBS symptoms as abdominal pain and difficult bowel movements in 66% of patients. Besides this, Alflorex® is also distinguished through the fact that it does not have to be refrigerated, with its capsules easy to take and implemented into a daily routine. Finally, their highly affordable nature sees premium digestive health afforded to all, without breaking the bank. This is something reflected in countless glowing testimonials from customers, including this one: “What I’ve been looking for years! I’ve had painful IBS with lots of bloating for years and years, and this product has worked wonders. My stomach is now comfortable every day, and they are easy and quick to take (no faffing around with fridges and liquids). No more evening bloats and painful gas. They are also very reasonably priced, so I will definitely be buying more!” More customers reviews can be found both here and on Trustpilot. In a market defined by increasing life expectancy, the prominence of preventative health, a shift towards personalised and technology-driven treatments, and constant regulatory changes, PrecisionBiotics®’ newly acquired status as a part of Novonesis Human Health BioSolutions, a leading global bioscience company, is ensuring its future successes. Now able to access a broader range of technologies and expertise, the company’s future will entail increased specialisation, greater marketing efforts, and further investing in online resources. Finally, as for more recent projects that are being pioneered by PrecisionBiotics®, one of the most notable developments is in the category of female health, where the Daily Women’s Flora is pencilled for a September 2024 release. Having been formulated with the proven ASTARTE™ and LA 5® strains, this probiotic supports the vaginal microbiome and the area’s overall health. This is just the beginning of a female range that will live up to the quality standards continuously set by PrecisionBiotics®, resulting in this widespread industry acclaim. Contact: Julie Butt and Radwa Gamal Company: PrecisionBiotics® Web Address: https://www.precisionbiotics.co.uk/ Probiotic Precision
RkJQdWJsaXNoZXIy MTUyMDQwMA==